IDH1 and central nervous system cancer: Mutations in the isocitrate dehydrogenase 1 (IDH1) gene have been observed in multiple human tumor types, with the highest prevalence seen in low grade glioma (LGG) and secondary glioblastoma (GBM)1–4.